The relationship between renal function and prognosis after vitrectomy in Chinese proliferative diabetic retinopathy patients with type 2 diabetes mellitus

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000039698

Enrollment

Unknown

Registered

2020-11-06

Start date

2020-11-09

Completion date

Unknown

Last updated

2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic retinopathy

Interventions

grouped according to renal function:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) PDR which has definite indications for surgery and no absolute contraindications to surgery in general condition; (2) Vitrectomy for the target eye is performed for the first time; (3) Agree to join after fully understanding the informed consent of the clinical research.

Exclusion criteria

Exclusion criteria: (1) AIDS, syphilis, leukemia, etc; (2) Type 1 diabetes; (3) No rubeosis iris or NVG, uveitis, branch retinal vein occlusion, age-related macular degeneration, ocular trauma, endophthalmitis, etc; (4) <6 months follow-up after primary vitrectomy.

Design outcomes

Primary

Measure	Time frame
best-corrected visual acuity;central retinal thickness;	—

Countries

China

Contacts

Public ContactMeixia Zhang

West China Hospital of Sichuan University

zhangmeixia@scu.edu.cn+86 18980602236

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026